#liver transplant

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.

Immunocompromised people ages 12 and older are also eligible for an additional shot.

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.

Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.

Experts recommend no more than two drinks for men or one drink for women per day.

The drug, which blocks entry of HBV into liver cells, also prevents HDV replication.

Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.

Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.

A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.

Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes.

The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.

Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.